Drug helps 96% beat testicular cancer

A drug available here has been hailed as one of the reasons behind the soaring success rate in men in beating testicular cancer.

Figures published yesterday by the Cancer Research UK organisation showed survival rates for testicular cancer have now risen to more than 96%. That represents an increased survival rate of almost 30% compared with the 1970s.

Cancer experts attributed much of the increased survival rate to the use of a chemotherapy drug called Cisplatin, also used for bladder, lung, and ovarian cancers.